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Abstract
Background: The human norovirus (NV) circulates worldwide and is a major cause of epidemics, which have
increased in Taiwan since 2002. NV in acute gastroenteritis (AGE) and non-acute gastroenteritis (asymptomatic)
patients, including children and adults, have not been previously examined in Taiwan; therefore, we examined the
epidemiology and phylogeny of NV in AGE and asymptomatic patients of all ages.
Methods: 253 stool samples were collected from August 2011 to July 2012 (including 155 AGE and 98
asymptomatic samples in Taiwan) and analyzed using reverse transcription-polymerase chain reaction (RT-PCR) for
NV. Primers targeting the RNA-polymerase gene were used for RT-PCR to allow DNA sequencing of Taiwan NV
strains and phylogenetic analyses.
Results: NV was detected in 24 (9.5%) of 253 stool specimens using RT-PCR. NV was isolated from all age groups
(1 to 86 y) and those NV-positive samples were major identified from inpatients (79.2%, 19/24). Statistical analysis
showed that the NV infectious rate of AGE patients was statistically significant (P < 0.05) for age, season and water
type, respectively. Phylogenetic analyses of the RdRp region sequence showed that 24 NV isolates belonged to
Genogroup II Genotype 4 (GII.4). They were closely related to the epidemic strain in Taiwan in 2006, the GII.4-2006b
pandemic strain in 2006, and the GII.4-New Orleans strain in 2010.
Conclusion: This study is the first to examine NV in sporadic AGE and asymptomatic patients in Taiwan.
Furthermore, epidemic strains of isolated GII.4 were predominant in Taiwan during 2011 and 2012.
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Background
Viral gastroenteritis is a major threat with high morbid-
ity and mortality, especially in children, elderly people,
and immunocompromised people in developing and
developed countries. It is estimated that viral gastro-
enteritis is the cause of 30%-40% of infectious cases in
developed countries [1]. Human noroviruses (NV) are
the leading cause of epidemic acute non-bacterial gastro-
enteritis worldwide. Taiwan has experienced a substan-
tial increase in NV outbreaks and sporadic records since
2002 [2]. Enzyme-linked immunosorbent assays showed
that 20% of pediatric viral gastroenteritis cases were
caused by NV from 2004 to 2005 [3]. Four NV outbreaks
occurred in a psychiatric care center, and the mean inci-
dence rate of NV gastroenteritis in hospitalized patients
during these outbreaks was 12.7% from 2005 to 2007 [4].
NV belongs to the Caliciviridae family and has a single-
stranded RNA genome of 7.5-7.7 kb. They are currently
classified into 5 genogroups (GI to GV) [5], and only NV
GI, GII, and GIV have been associated with human gastro-
enteritis [6]. NV is spread through a number of pathways
with the occurrence of both fecal-oral and vomit-oral
transmission. Direct person-to-person transmission is a
primary mode of transmission in most outbreaks [7] and
sporadic diseases [8]. Furthermore, NV disease outbreaks
are reported year-round. They peak during months with
cold weather and temperate climates [9].
NV sporadic cases involving children have been reported
in Taiwan [10-13]. However, data on the molecular
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epidemiology (including epidemic genotyping, ages, and
seasonality) of NV infection in acute gastroenteritis (AGE)
and non-acute gastroenteritis (asymptomatic) patients in
Taiwan are limited. The objectives of the study were as fol-
lows: to determine the AGE and asymptomatic infection
rates of NV among hospital patients; to examine the asso-
ciation of patients age and of infection seasons with the
NV infection rates; to analyze the NV genotypes by RT-
PCR and sequencing methods.
Methods
Case definition
AGE patients were defined as patients with clinical diar-
rhea (≧3 loose stools within a 24 h period), which may
be accompanied by abdominal pain, fever, nausea, and
vomiting. Asymptomatic patients were defined as pa-
tients undergoing routine medical examinations without
symptoms of clinical diarrhea.
Specimen collection
This study was approved by the Human Subject Research
Ethics Committee of the Wei-Gong Memorial Hospital
and the approval number was 100003. Informed written
consent was obtained from adult participants and parents
of minors. This study was conducted from August 2011 to
July 2012 at Wei-Gong Memorial Hospital in Taiwan. The
stools of 253 patients (155 AGE and 98 asymptomatic
patients) were collected. The stool samples were stored
at −20°C before transfer on ice blocks to the Department
of Bioengineering, Tatung University, where they were
stored at −70°C. The samples were frozen (−70°C) before
or after initial analysis as fecal suspensions. The samples
were examined for the presence of NV using RT-PCR be-
fore storage in a balanced salt solution at 10% suspensions
at −70°C until use.
Nucleic acid extraction and RT-PCR
Nucleic acid was extracted using a viral nucleic acid ex-
traction kit (Geneaid, Taiwan) from 200 μL of 10% fecal
suspension to a final volume of 50 μL of RNase-free
H20. RT-PCR for NV was performed using 10 μL nucleic
acid with 10 μL of RT-PCR mix (Qiagen, Taiwan)
containing the RT-PCR mix for NV contained 0.5 μL
(10 μM) of JV12 (5’ATACCACTATGATGCAGATTA-3’,
nucleotides location 4552–4572) and JV13 (5’-TCATC
ATCACCATAGAAAGAG-3’, nucleotides location 4878–
4858) primers [14], a 4 μL buffer, 0.4 μL (10 mM) dNTPs,
3.8 μL H2O, and 0.8 μL (1.25 U/μL) of enzyme mix. The
thermal conditions for NV-specific one-step RT-PCR were
50°C for 30 min and 95°C for 15 min, 40 cycles at 94°C for
30 s, 37°C for 1 min, and 72°C for 1 min, followed by a
final extension of 72°C for 10 min. The amplicons were
analyzed in 2% agarose gel electrophoresis at 100 V for
30 min and visualized under UV light after ethidium
bromide staining. Positive PCR products were stored
at −20°C. All NV positive samples were subjected to se-
quence and phylogenetic analyses.
Sequence and phylogenetic analyses
NVs were identified based on nucleotide sequences of
the RNA-dependent RNA polymerase (RdRp) region,
which comprised 327 bp for the positive control. All NV
PCR product sequences were analyzed using the basic
local alignment search tool (BLAST) and DNAMAN
software. Phylogenetic trees with 1000 bootstrap repli-
cates were generated using the neighbor-joining method
by employing molecular evolutionary genetics analysis
(MEGA), version 5.0. Reference strains were downloaded
from the GenBank. Only bootstrap values >65 were con-
sidered significant.
Statistical analysis
For categorical variables, the chi-square test was used to
examine differences in proportions between groups. P
values < 0.05 were considered statistically significant. Fish-




During the study period, 253 patients (including children
and adults) comprising 136 (53.8%) males were enrolled.
Among them, 155 (61.3%) were AGE patients. The sam-
ples (including 53 obtained from outpatients, 6 from
emergency unit, and 194 from inpatients) were collected
and screened for NV. All sample characteristics by the
enrolment site are shown in Table 1.
NV positive rates and clinical features
NV was detected in 24 (9.5%) of all samples, 17 (11%) in
AGE patients, and 7 (7.1%) in asymptomatic patients. The
clinical feature of NV that detected in AGE and asymp-
tomatic patients, were fever, vomiting, and abdominal pain
(Table 1). AGE patients with NV-positive were signifi-
cantly higher in fever and in vomiting than with NV-
negative (Table 1). Clinical symptoms of NV-positive AGE
include fever (61.1%, 11/18), vomiting (42.1%, 8/19),
watery stool (42.1%, 8/19), and abdominal pain (50%, 9/
18) (Table 2).
Epidemiological features
AGE patients with NV-positive were more likely to
drink spring water than NV-negative patients (23.5%,
4/17 versus 5.1%, 7/138) (Table 1). NV infections were
identified in AGE patients of all ages (1 to 86 y)
(Table 2). NV was detected more often in AGE pa-
tients less than 10 years old (52.9%, 9/17 versus 16.7%,
23/138), and those greater than 40 years old (29.4%, 5/
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Table 1 Epidemiological and clinical features by examine NV in AGE, asymptomatic patients
AGE patients (n = 155) Asymptomatic patients (n = 98)
NV Negative NV Negative
Parameter (n = 17) (n = 138) Pa ORd 95% CId (n = 7) (n = 91) Pb
Detection rate (%) 11 - 7.1 -
Sex (male: female) 10:7 74:64 5:2 47:44
Setting
Outpatient (38,15) c 2(11.8) 36(26.1) - - - 3(42.8) 12(13.2) -
Emergency (6,0) c - 6(4.3) - - - - - -
Inpatient (111,83) c 15(88.2) 96(69.6) - - - 4(57.2) 79(86.8) -
Age
<10 9(52.9) 23(16.7) 0.002 5.6 2.0-16.1 1(14.3) 4(4.4) -
10-40 3(17.7) 28(20.3) - - 2(28.6) 5(5.5) -
>40 5(29.4) 87(63.0) 0.016 0.2 0.1-0.7 4(57.1) 82(90.1) -
Season
Spring 3(17.6) 54(39.1) - - - - 23(25.3) -
Summer 2(11.8) 42(30.4) - - - 4(57.1) 45(49.4) -
Fall 2(11.8) 10(7.3) - - - - 10(11.0) -
Winter 10(58.8) 32(23.2) 0.004 4.7 1.7-13.4 3(42.9) 13(14.3) -
Water type
Tap water 12(70.6) 118(85.5) - - - 6(85.7) 81(89.0) -
Underground water - 2(1.4) - - - - - -
Spring water 4(23.5) 7(5.1) 0.022 5.8 1.5-22.3 - 2(2.2) -
Miss data 1(5.9) 11(8.0) - - - 1(14.3) 8(8.8) -
Fever >38°C (%) - -
Yes 9(52.9) 47(34.1) - 2.5 0.9-7.1 2(28.6) 21(23.1) -
No 7(41.2) 91(65.9) - - - 5(71.4) 70(76.9) -
Miss data 1(5.9) - - - - - - -
Vomiting
Yes 7(41.2) 28(20.3) - 2.7 0.9-7.7 - 6(6.6) -
No 10(58.8) 108(78.3) - - - 7(100) 85(93.4) -
Miss data - 2(1.4) - - - - - -
Stool type
Watery 8(47.1) 49(35.5) - - - - 1(1.1) -
Bloody 1(5.8) 18(13.0) - - - - 3(3.3) -
Non-watery, non-bloody 8(47.1) 71(51.5) - - - 7(100) 87(95.6) -
Abdominal pain
Yes 9(52.9) 84(60.9) - - - - 19(20.9) -
No 7(41.2) 52(37.7) - - - 7(100) 72(79.1) -
Miss data 1(5.9) 2(1.4) - - - - - -
Only significant p value (<0.05) reported.
a two-tailed Chi-Square, Fisher’s exact test comparing AGE patient and negative cases.
b two-tailed Chi-Square, Fisher’s exact test comparing asymptomatic patient and negative cases.
c the table in parentheses refer to the former is AGE patients and the latter is asymptomatic patients number.
d OR odds ratio, CI confidence interval.
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17 versus 63%, 87/138) (Table 1 and Figure 1). How-
ever, asymptomatic patients with NV-positive were
identified both from <2 and from >20 years old. Those
NV-positive samples were major identified from inpa-
tients (79.2%, 19/24) (Table 2). NV infections were
identified throughout the year (highest incidence in
December, followed by October) among patients and
controls. NV was detected in AGE patients more often
in the winter than in the other seasons (Table 1 and
Figure 2).
Phylogenetic analyses
Twenty-four NVs that were identified and sequenced
belonged to the NV Genogroup II.4 (GII.4). Three GII.4
variants (GII.4-2006b, GII.4-2010tw, and GII.4-New
Orleans variants) were identified, as shown in Figure 3.
Discussion
NVs are the leading cause of AGE among people [15].
NV is associated with 6%-25% of AGE patients world-
wide [16-20]. Previous studies have indicated that the
Table 2 Characteristics of NV-associated with AGE and asymptomatic patients
No. Years Location Genotype AGE Fever Vomiting Stool Abdominal pain
2 13 Inpatient GII.4 Ya Y Y Nnb Miss
10 5 Inpatient GII.4 Y Y N Nn N
14 40 Inpatient GII.4 Na N N Nn N
22 22 Outpatient GII.4 Y N N Watery N
27 7 Inpatient GII.4 Y Y Y Watery Y
31 1 Inpatient GII.4 Y Y N Nn N
37 46 Outpatient GII.4 N N N Nn N
40 6 Inpatient GII.4 Y Y Y Watery Y
41 31 Outpatient GII.4 N N N Nn N
44 50 Inpatient GII.4 Y N N Watery Y
45 2 Inpatient GII.4 Y Y N Watery N
49 86 Inpatient GII .4 Y Y N Nn Y
51 68 Inpatient GII.4 Y N N Nn Y
54 17 Outpatient GII.4 Y N Y Nn N
56 1 Inpatient GII.4 Y Y N Watery N
84 71 Inpatient GII .4 Y Miss N Nn N
107 2 Inpatient GII.4 Y N Y Watery Y
122 2 Inpatient GII.4 Y Y Y Watery Y
171 1 Inpatient GII.4 Y N Y Nn Y
183 75 Inpatient GII.4 N Y N Nn N
184 82 Inpatient GII.4 Y N Y Bloody Y
191 66 Inpatient GII.4 N N N Nn N
193 1 Inpatient GII.4 N Y N Nn N
203 75 Outpatient GII.4 N N N Nn N
a:Y Yes, N No.
b:Nn Non-watery, non-bloody stool.
Figure 1 Monthly distribution of NV-associated with in AGE
and asymptomatic patients.
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NV positive rate differs significantly between AGE
(16.1%) and asymptomatic (5.2%) [21]. The NV positive
rate (11%) among AGE patients in this study was similar
to those in Taiwan (10.5%) [22] and Australia (11.4%)
[23]. In this study, the NV positive detection rate al-
though was so low, but its prevalence rate was in ac-
cordance with other reports about the recent Taiwan
situation (2007 prevalence of 8.2%, 2010 prevalence of
14.6%) [10,12]. The major reason to explain why NV
positive rate so low was the lower gastroenteritis fecal
samples. So we will continue to collect more gastro-
enteritis fecal samples in the next year. Furthermore, the
NV positive rate (7.1%) among asymptomatic patients
was similar to that in India (7.5%) [24]. Therefore, this
study shows that the predominance of NV infections in
Taiwan is a pandemic and may indicate the circulation
of this strain in this region.
A previous study indicated that GII.4 strains of NV
were dominant in AGE and asymptomatic patients dur-
ing a recent hospital outbreak [25]. This result is similar
to that obtained in this study. The GII.4 strains are a
major cause of sporadic occurrences of AGE. Although
NV GII.4 strains are widespread, they do not always cause
AGE, which may account for the increased number of in-
fections through asymptomatic transmission routes [26].
Furthermore, the population usually includes asymptom-
atic carriers of NV related to the occurrence of NV out-
breaks [27]. Therefore, commonly occurring NV infections
may result from multiple routes of transmission, especially
for asymptomatic patients with NV pathways.
A previous study [28] indicated that the NV positive
rate of AGE patients differs significantly between inpa-
tients (16.7%) and outpatients (9.2%). The NV positive
rate for AGE and asymptomatic patients that from inpa-
tients and outpatients (Table 1) was similar to that of
recent studies [21,24,29-35]. Therefore, in this study, the
result appeared that AGE patients with NV-positive
from inpatients were higher than from outpatients.
Among all NV GII.4 samples in this study, those sam-
ples were inpatients (79.2%) and outpatients (20.8%),
respectively. Similar to a previous study [36], the analysis
indicated that severe outcomes are associated with NV
GII.4 infections. Therefore, epidemic strains of isolated
GII.4 may cause severe clinical symptoms, and patients
may require hospitalization.
NV in AGE patients was significantly associated with
the consumption of spring water [37]. Previous studies
are consistent with our observation that AGE-related
NV infections are significantly related to the consump-
tion of spring water. Similar to a previous study, the
analysis indicated that the GII strain was associated with
spring water (OR = 3.8). The consumption of spring
water is a risk factor and suspected transmission route.
A previous study indicated that NV in AGE patients was
significantly associated with clinical symptoms [38]. This
was similar to our observation that AGE-related NV in-
fections have marginal statistical significance related to
the diagnosis of fever and vomiting. The analysis also in-
dicated that the GII strain was associated with vomiting.
Both fever and vomiting are risk factors and may be
used by clinicians for the clinical diagnosis of acute
gastroenteritis in patients.
NV is a leading cause of sporadic gastroenteritis in chil-
dren and adults. It is a common cause of hospitalization
for gastroenteritis, especially among vulnerable popula-
tions (young children and elderly people). Similar to the
results of previous studies [39], AGE-related NV infec-
tions have statistical significance in patients aged <10 and
>40 years old compared to other age groups. It indicated
that young children and elderly people may be at risk of
NV infection. In this study, patients aged 1 to 86 years
were infected with NV, indicating NV infections in all age
groups. This indicated the predominance of NV infections
in young children and elderly people, and may provide
health authorities in Taiwan with control strategies to pre-
vent person-to-person NV transmission.
Transmission of NV infections occurred year-round in
most surveys, and a cold weather peak was observed in
11 of the 12 studies [9]. The detection rate of AGE-
related NV infections is significantly greater during the
winter compared to the other seasons [40,41]. This epi-
demiologic feature of NV has crucial implications re-
garding the mode of transmission and understanding the
etiology of gastroenteritis in children and adults.
Human diseases are primarily caused by GI and GII
NVs, and most outbreaks are caused by GII.4 strains
[42]. The major pandemic genotype of NV in the world
was GII.4, also include Taiwan [2,4]. New GII.4 strains
have emerged every 2–3 y over the past decade, and have
replaced previously predominant GII.4 strains [43,44]. In
the previous study, it also indicated that NV GII was
prevalent in some area only, without GI [45,46]. The
similar result was appeared in this study. Furthermore, it
had ever been proved that the major cause of one
Figure 2 Age group distribution of NV-associated with AGE and
asymptomatic patients.
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gastroenteritis outbreak in Taiwan was NV GII.4 (100%,
31/31) only [47]. So we believed that only NV GII.4 did
prevalent in the gastroenteritis patients in this study. NV
GII.4-2006b was associated with sporadic gastroenteritis
and was a globally circulating strain in several countries,
including Japan, China, and Italy [48-50]. From previous
reports [48,49] and our result, it proved that AGE patients
infected with NV GII.4-2006b could be more prevalent in
Figure 3 Phylogenetic tree based on nucleotide sequence of the NV RdRp region, the reference strain designation is the Genbank
access number followed by the genotype designation. In this study, the isolated strain designation is the Wei-Gong (WG) hospital
sample number.
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younger children and in winter season. The total GII.4
isolate strains were closely related to the epidemic strain
in Taiwan in 2006, the GII.4-2006b pandemic strain in
2006, and the strain in New Orleans (United States) in
2010. It is crucial to emphasize the existence of 2 variants
of GII.4 (GII.4-2006b and GII.4-New Orleans) in Taiwan.
NV GII.4 variant strains implicated in sporadic gastro-
enteritis worldwide also occurred in Taiwan, indicating
global spread.
Conclusion
In summary, this study is the first to examine NV in
sporadic AGE and asymptomatic patients in Taiwan. The
results showed that the season and age distribution for
NV-positive patients were similar to those in previous NV
studies worldwide. Furthermore, our results indicated that
epidemic strains of isolated GII.4 were predominant in
Taiwan during 2011 and 2012. Systematic surveillance and
evidence-based studies are required to determine the
transmission pathways and spread of NV.
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